Primary hyperaldosteronism natural history, complications and prognosis: Difference between revisions
Usama Talib (talk | contribs) No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Primary hyperaldosteronism}} | {{Primary hyperaldosteronism}} | ||
{{CMG}};{{AE}}{{HK}} | |||
==Overview== | |||
If left untreated, patients with primary hyperaldosteronism may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3]. Common complications of [disease name] include [complication 1], [complication 2], and [complication 3]. Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [#]%. | |||
==Natural History== | |||
==Complications== | |||
==Prognosis== | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} |
Revision as of 16:23, 18 July 2017
Primary hyperaldosteronism Microchapters |
Differentiating Primary Hyperaldosteronism from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Primary hyperaldosteronism natural history, complications and prognosis On the Web |
American Roentgen Ray Society Images of Primary hyperaldosteronism natural history, complications and prognosis |
FDA on Primary hyperaldosteronism natural history, complications and prognosis |
CDC on Primary hyperaldosteronism natural history, complications and prognosis |
Primary hyperaldosteronism natural history, complications and prognosis in the news |
Blogs on Primary hyperaldosteronism natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Syed Hassan A. Kazmi BSc, MD [2]
Overview
If left untreated, patients with primary hyperaldosteronism may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3]. Common complications of [disease name] include [complication 1], [complication 2], and [complication 3]. Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [#]%.